Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mano, M. S.
Right arrow Articles by Awada, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mano, M. S.
Right arrow Articles by Awada, A.
Related Collections
Right arrow 2004 - Review Articles
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 15:1161-1171, 2004
© 2004 European Society for Medical Oncology

Review

Primary chemotherapy for breast cancer: the evidence and the future

The first generation of randomised trials assessing the role of primary chemotherapy in breast cancer has failed to demonstrate the expected survival benefit. However, it has established the role of this treatment in ‘downstaging’ tumours of patients with locally advanced disease and, consequently, in improving breast conservation rates. Also, a number of surrogates of outcome have been identified, which will hopefully lead to earlier results in breast cancer clinical trials. Encouraging results have also been reported in trials investigating a number of novel approaches.

M. S. Mano1,* and A. Awada2

1 Beatson Oncology Centre, Department of Medical Oncology, Glasgow, UK; 2 Institut Jules Bordet, Unité de Chimiothérapie, Brussels, Belgium

* Correspondence to: Dr M. S. Mano, Beatson Oncology Centre, Department of Medical Oncology, Dumbarton Road, Glasgow G11 6NT, UK. Tel: +44-141-2116299; Fax: +44-141-2111866; E-mail: max_mano{at}hotmail.com

Key words: breast cancer, breast conserving surgery, neoadjuvant chemotherapy, primary chemotherapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
D. J. Kerr
Teenage kicks
Ann. Onc., January 1, 2005; 16(1): 1 - 2.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.